Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:00 AM ET 10-K
Financial Results Hartman vREIT XXI, Inc.

Hartman vREIT XXI FY 2024 Results: Turns Profitable, Net Income $2.04M

Hartman vREIT XXI, Inc. filed its annual report for the fiscal year ending 2026, detailing its portfolio of commercial real estate assets and operational performance. The report focuses on rental income stability, property management efficiencies, and the company's liquidity position as a non-traded real estate investment trust.

Key figure
Net income $2.04M
6:00 AM ET 10-Q
Financial Results Emergent BioSolutions Inc. EBS

Emergent BioSolutions Q3 2026 Results: Net Loss of $32.7M

Emergent BioSolutions reported total assets of $995.2 million as of September 30, 2026, a decrease from $1,318.6 million at year-end 2025. The company is navigating significant debt obligations under a new 2026 Term Loan Agreement and is focused on its medical countermeasure (MCM) contracts with the U.S. government and the commercial performance of NARCAN Nasal Spray.

Key figure
Net loss $32.7M
6:00 AM ET 8-K
Loan & Debt Tevogen Inc. TVGN

Tevogen $36M Debt Financing with The Patel Family, LLP

Tevogen Inc. amended its unsecured line of credit with The Patel Family, LLP, extending the borrowing period to May 31, 2029, and fixing the share price for debt repayment at $7.40 per share. Following the amendment, the company issued approximately 1.02 million shares to repay the entire $7.4 million outstanding principal balance and accrued interest, effectively eliminating its current debt liabilities.

Value
$36M
Counterparty
The Patel Family, LLP
Term
through May 2029
9:50 PM ET Form 4
Insider Buying Aspen Neuroscience, Inc. ASPE

Aspen Neuroscience 10% Owner ARCH Venture Fund X L.P. Buys $20M of Stock

ARCH Venture Fund X L.P., 10% Owner, bought 1,333,333 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $20M in total on Nov 2, 2026. Shares held after the trade: 1,200,000.

Value
$20M
Shares
1,333,333
Average price
$15.00
Role
10% Owner
Trade date
Nov 2, 2026
9:47 PM ET Form 4
Insider Buying Aspen Neuroscience, Inc. ASPE

Aspen Neuroscience 10% Owner ARCH Venture Partners XIV L.P. Buys $18M of Stock

ARCH Venture Partners XIV L.P., 10% Owner, bought 1,200,000 shares of Aspen Neuroscience, Inc. at $15.00 a share, worth $18M in total on Nov 2, 2026. Shares held after the trade: 1,200,000.

Value
$18M
Shares
1,200,000
Price
$15.00
Role
10% Owner
Trade date
Nov 2, 2026
8:45 PM ET Form 4
Insider Buying Hamilton Lane Venture Capital & Growth Fund

Hamilton Lane Venture Capital & Growth Fund Insider Hamilton Lane Advisors LLC Buys $36.5M of Stock

Hamilton Lane Advisors LLC bought 1,824,686 shares of Hamilton Lane Venture Capital & Growth Fund at $12.99 to $20.50 a share (average $20.02) in 2 transactions, worth $36.5M in total between Jul 28, 2025 and Oct 29, 2026. Shares held after the trade: 2,396,201 (+247.8%).

Value
$36.5M
Shares
1,824,686
Average price
$20.02
Holding change
+247.8%
Trade date
Jul 28, 2025 to Oct 29, 2026
8:00 PM ET Form 4
Insider Selling CrowdStrike Holdings, Inc. CRWD

CrowdStrike Holdings President and CEO George Kurtz Sells $5.05M of Stock

George Kurtz, President and CEO, sold 19,800 shares of CrowdStrike Holdings, Inc. at $246.13 to $267.66 a share (average $255.10) in 29 transactions, worth $5.05M in total between Oct 29, 2026 and Oct 30, 2026. Shares held after the trade: 7,341,704 (-0.0%).

Value
$5.05M
Shares
19,800
Average price
$255.10
Role
President and CEO
Holding change
-0.0%
Trade date
Oct 29, 2026 to Oct 30, 2026
8:00 PM ET Form 4
Insider Selling CrowdStrike Holdings, Inc. CRWD

CrowdStrike Holdings President and CEO George Kurtz Sells $52.3K of Stock

George Kurtz, President and CEO, sold 200 shares of CrowdStrike Holdings, Inc. at $261.60 a share, worth $52.3K in total on Oct 30, 2026. Shares held after the trade: 7,341,504 (-0.0%).

Value
$52.3K
Shares
200
Price
$261.60
Role
President and CEO
Holding change
-0.0%
Trade date
Oct 30, 2026
7:59 PM ET Form 4
Insider Selling CME Group Inc. CME

CME Group Sr MD Chief Commercial Officer Julie Winkler Sells $3.08M of Stock

Julie Winkler, Sr MD Chief Commercial Officer, sold 10,079 shares of CME Group Inc. at $305.15 a share, worth $3.08M in total on Nov 2, 2026. Shares held after the trade: 21,482 (-31.9%).

Value
$3.08M
Shares
10,079
Price
$305.15
Role
Sr MD Chief Commercial Officer
Holding change
-31.9%
Trade date
Nov 2, 2026
7:47 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CFO Houte Hans van Sells $74.5K of Stock

Houte Hans van, CFO, sold 2,834 shares of Nurix Therapeutics, Inc. at $26.28 a share, worth $74.5K in total on Oct 30, 2026. Shares held after the trade: 47,514 (-5.6%).

Value
$74.5K
Shares
2,834
Price
$26.28
Role
CFO
Holding change
-5.6%
Trade date
Oct 30, 2026
7:45 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CLO Christine Ring Sells $104K of Stock

Christine Ring, CLO, sold 3,957 shares of Nurix Therapeutics, Inc. at $26.28 a share, worth $104K in total on Oct 30, 2026. Shares held after the trade: 15,335 (-20.5%).

Value
$104K
Shares
3,957
Price
$26.28
Role
CLO
Holding change
-20.5%
Trade date
Oct 30, 2026
7:42 PM ET Form 4
Insider Selling Nurix Therapeutics, Inc. NRIX

Nurix Therapeutics CSO Gwenn Hansen Sells $143K of Stock

Gwenn Hansen, CSO, sold 5,409 shares of Nurix Therapeutics, Inc. at $26.28 to $26.80 a share (average $26.42) in 2 transactions, worth $143K in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 123,452 (-1.2%).

Value
$143K
Shares
5,409
Average price
$26.42
Role
CSO
Holding change
-1.2%
Trade date
Oct 30, 2026 to Nov 2, 2026
7:38 PM ET Form 4
Insider Selling AerCap Holdings N.V. AER

AerCap Holdings General Counsel Vincent Drouillard Sells $1.58M of Stock

Vincent Drouillard, General Counsel, sold 10,000 shares of AerCap Holdings N.V. at $158.14 a share, worth $1.58M in total on Oct 29, 2026. Shares held after the trade: 81,623 (-10.9%).

Value
$1.58M
Shares
10,000
Price
$158.14
Role
General Counsel
Holding change
-10.9%
Trade date
Oct 29, 2026
7:15 PM ET Form 4
Insider Selling Gilead Sciences, Inc. GILD

Gilead Sciences Chairman & CEO Daniel Patrick O'Day Sells $5.33M of Stock

Daniel Patrick O'Day, Chairman & CEO, sold 30,881 shares of Gilead Sciences, Inc. at $167.40 to $175.25 a share (average $172.57) in 6 transactions, worth $5.33M in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 551,683 (-0.4%).

Value
$5.33M
Shares
30,881
Average price
$172.57
Role
Chairman & CEO
Holding change
-0.4%
Trade date
Oct 30, 2026 to Nov 2, 2026
7:10 PM ET Form 4
Insider Selling Pitney Bowes Inc PBI

Pitney Bowes President & CEO Kurt James Wolf Sells $3.33M of Stock

Kurt James Wolf, President & CEO, sold 201,517 shares of Pitney Bowes Inc at $16.23 to $17.45 a share (average $16.54) in 4 transactions, worth $3.33M in total between Oct 29, 2026 and Nov 2, 2026. Shares held after the trade: 73,184 (-15.6%).

Value
$3.33M
Shares
201,517
Average price
$16.54
Role
President & CEO
Holding change
-15.6%
Trade date
Oct 29, 2026 to Nov 2, 2026
7:03 PM ET Form 4
Insider Selling Slb Limited SLB

Slb CEO Peuch Olivier Le Sells $1.32M of Stock

Peuch Olivier Le, CEO, sold 25,000 shares of Slb Limited at $52.90 a share, worth $1.32M in total on Nov 2, 2026. Shares held after the trade: 1,246,328 (-2.0%).

Value
$1.32M
Shares
25,000
Price
$52.90
Role
CEO
Holding change
-2.0%
Trade date
Nov 2, 2026
7:01 PM ET Form 4
Insider Selling Fortive Corp FTV

Fortive VP - CAO Christopher M. Mulhall Sells $1.71M of Stock

Christopher M. Mulhall, VP - CAO, sold 26,055 shares of Fortive Corp at $65.56 to $65.57 a share (average $65.56) in 2 transactions, worth $1.71M in total on Oct 30, 2026. Shares held after the trade: 15,597 (-34.2%).

Value
$1.71M
Shares
26,055
Average price
$65.56
Role
VP - CAO
Holding change
-34.2%
Trade date
Oct 30, 2026
7:01 PM ET Form 4
Insider Selling Fortive Corp FTV

Fortive SVP - CLO Peter C. Underwood Sells $3.13M of Stock

Peter C. Underwood, SVP - CLO, sold 48,442 shares of Fortive Corp at $64.60 a share, worth $3.13M in total on Oct 30, 2026. Shares held after the trade: 79,118 (-38.0%).

Value
$3.13M
Shares
48,442
Price
$64.60
Role
SVP - CLO
Holding change
-38.0%
Trade date
Oct 30, 2026
6:49 PM ET Form 4
Insider Selling Rimini Street, Inc. RMNI

Rimini Street EVP & Chief Revenue Officer Steven Hershkowitz Sells $211K of Stock

Steven Hershkowitz, EVP & Chief Revenue Officer, sold 42,482 shares of Rimini Street, Inc. at $4.98 a share, worth $211K in total on Nov 2, 2026. Shares held after the trade: 186,992 (-18.5%).

Value
$211K
Shares
42,482
Price
$4.98
Role
EVP & Chief Revenue Officer
Holding change
-18.5%
Trade date
Nov 2, 2026
6:27 PM ET Form 4
Insider Buying Rush Street Interactive, Inc. RSI

Rush Street Interactive Insider Thomas Winter Buys $118K of Stock

Thomas Winter bought 10,000 shares of Rush Street Interactive, Inc. at $11.83 a share, worth $118K in total on Nov 2, 2026. Shares held after the trade: 30,497 (+48.8%).

Value
$118K
Shares
10,000
Price
$11.83
Holding change
+48.8%
Trade date
Nov 2, 2026
6:25 PM ET Form 4
Insider Selling Medpace Holdings, Inc. MEDP

Medpace Holdings General Counsel & Corp. Secy. Stephen P. Ewald Sells $859K of Stock

Stephen P. Ewald, General Counsel & Corp. Secy., sold 1,245 shares of Medpace Holdings, Inc. at $690.00 a share, worth $859K in total on Oct 29, 2026. Shares held after the trade: 19,098 (-6.1%).

Value
$859K
Shares
1,245
Price
$690.00
Role
General Counsel & Corp. Secy.
Holding change
-6.1%
Trade date
Oct 29, 2026
6:23 PM ET Form 4
Insider Buying Northern Trust Corp NTRS

Northern Trust Insider Robert Edward Moritz Jr. Buys $39.9K of Stock

Robert Edward Moritz Jr. bought 236 shares of Northern Trust Corp at $169.07 a share, worth $39.9K in total on Oct 30, 2026. Shares held after the trade: 8,636 (+2.8%).

Value
$39.9K
Shares
236
Price
$169.07
Holding change
+2.8%
Trade date
Oct 30, 2026
6:18 PM ET Form 4
Insider Selling Cytokinetics Inc CYTK

Cytokinetics President & CEO Robert I. Blum Sells $471K of Stock

Robert I. Blum, President & CEO, sold 7,500 shares of Cytokinetics Inc at $62.81 a share, worth $471K in total on Nov 2, 2026. Shares held after the trade: 278,544 (-2.6%).

Value
$471K
Shares
7,500
Price
$62.81
Role
President & CEO
Holding change
-2.6%
Trade date
Nov 2, 2026
6:11 PM ET Form 4
Insider Selling Etsy Inc ETSY

Etsy Director Josh Silverman Sells $3.93M of Stock

Josh Silverman, Director, sold 42,689 shares of Etsy Inc at $88.70 to $92.13 a share (average $92.03) in 2 transactions, worth $3.93M in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 221,117 (-15.8%).

Value
$3.93M
Shares
42,689
Average price
$92.03
Role
Director
Holding change
-15.8%
Trade date
Oct 30, 2026 to Nov 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.